A pharmaceutical company in the UK is voluntarily recalling 34 lots of veterinary injectable drug products due to sterility concerns, according to the FDA. Norbrook Laboratories in Newry, Northern Ireland, issued the recall May 24, that if the sterility of these drugs has been compromised, using them could introduce infectious agents to the animals.
Low-income Americans are having a hard enough time feeding themselves. Feeding their pets is an even bigger challenge. Some 42 million Americans received benefits from the Supplemental Nutrition Assistance Program (SNAP) last year.
AAHA-Accredited Hospital Day marks a celebration of the superstars who uphold the AAHA Standards of Accreditation an d continuously pursue better care for all patients, clients, and team members . G ive your favorite AAHA-accredited vet team a high five today . They’ve earned it!
A new study by researchers at the University of Pennsylvania’s Perelman School of Medicine and the School of Veterinary Medicine reviewed all opioids dispensed at the veterinary school for from January 2007 through December 2017. The findings show that prescriptions rose 41% annually, while the number of patient visits rose only 13%.The researchers found the ratio worrisome.
“Veterinarians who want to report suspected animal abuse often encounter a bureaucratic runaround,” says Phil Arkow. Arkow hopes that the recent launch of a free online National Directory of Abuse Investigation Agencies will help. Arkow is Coordinator of the National Link Coalition, a multidisciplinary, collaborative initiative formed in 2008 to raise awareness of the connection between animal abuse, child abuse, and domestic violence. It’s based on the idea that violence begets violence, and that when animal cruelty or neglect exists in a home, chances are that children, domestic partners, or elderly family members are being hurt, too.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.